SCHEMBL5484448

SCHEMBL5484448

Nc1ccccc1-c1nccc(-c2ccccc2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.59
HSP90AA1 P07900 2/20 0.59
AURKA O14965 1/20 0.59
PRKACA P17612 1/20 0.59
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 1/20 0.50
ADORA3 P0DMS8 1/20 0.46
ASIC3 Q9UHC3 2/20 0.46
ACE2 Q9BYF1 1/20 0.44
PIM1 P11309 1/20 0.43
PIM3 Q86V86 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 2/20 0.43
GABRA1 P14867 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15876511 0.87 ALDH1A1 (0.46) ADORA2AHSP90AA1AURKAPRKACAALDH1A1
SCHEMBL710851 0.85 AURKA (0.44) ADORA2AHSP90AA1AURKAPRKACAALDH1A1
SCHEMBL29177730 0.83 AURKA (0.55) ADORA2AHSP90AA1AURKAPRKACAALDH1A1
SCHEMBL27786703 0.79 CYP1A2 (0.54) ADORA2AHSP90AA1AURKAPRKACAALDH1A1
SCHEMBL29620532 0.78 AURKA (0.63) ADORA2AHSP90AA1AURKAPRKACAKMT2A
SCHEMBL190954 0.78 AURKA (0.63) ADORA2AHSP90AA1AURKAPRKACAKMT2A
SCHEMBL18732404 0.77 MAPT (0.49) ADORA2AHSP90AA1AURKAPRKACAALDH1A1
SCHEMBL7467793 0.77 ABL1 (0.45) ADORA2AHSP90AA1AURKAPRKACAACE2
SCHEMBL29736136 0.77 AURKA (0.61) ADORA2AHSP90AA1AURKAPRKACAASIC3
Ammonia Solution, Strong SCHEMBL20267253 0.77 AURKA (0.61) ADORA2AHSP90AA1AURKAPRKACAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021419-A1 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors CYCLACEL LIMITED (GB) 2007-01-25 US disclosed
CN-1860104-A 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors CYCLACEL LTD (GB) 2006-11-08 CN disclosed
CN-1860104-A 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors CYCLACEL LTD (GB) 2006-11-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021419-A1 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors GRK3, NCOR1, GRM3 ADORA2A 1950/4885HSP90AA1 4272/4885AURKA 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.